Table 1. Demographics.
CHR+ (N=5) | CHR− (N=29) | |
---|---|---|
Age (in years) | 22.2 (3.4) | 21.2 (3.6) |
Gender (% male) | 80% | 66% |
Race (% Caucasian) | 40% | 38% |
Medications prescribed (antipsychotics and/or antidepressants) | 20% | 21% |
Abbreviations: CHR+, clinical high-risk participants who transitioned to psychosis during follow-up; CHR−, clinical high-risk participants who did not transition to psychosis during follow-up.